Valuation best practices: Answering the 'frequency' question
September 11, 2018
- Share:
By Mark Emrich, Managing Director, Business Development, Murray Devine Valuation Advisors
This past August, when President Donald Trump conveyed via Twitter that he had asked the SEC to study the possibility of moving from a quarterly to a biannual reporting schedule, the investment community at large took notice. While such a move ultimately seems unlikely—particularly given the transparency premium afforded to domestic stocks—it does bring to mind pressing questions around reporting frequency that are common among private-market participants. More specifically, while there is general agreement that a quarterly reporting cadence is usually appropriate, how private equity fund managers corroborate their internal assessments of fair value and the frequency at which they provide independent third-party validations can differ considerably across the GP universe.
As long as fair value remains something of a subjective measure, however, the prevailing question for GPs will revolve around the amount of rigor that goes into third-party validations and when, exactly, these independent assessments should accompany portfolio-company reporting. The easy answer—that it depends on the strategy and structure of the specific fund—is typically less than satisfying.
Read more
This article represents the author's views only and doesn't necessarily represent the views of PitchBook.
This past August, when President Donald Trump conveyed via Twitter that he had asked the SEC to study the possibility of moving from a quarterly to a biannual reporting schedule, the investment community at large took notice. While such a move ultimately seems unlikely—particularly given the transparency premium afforded to domestic stocks—it does bring to mind pressing questions around reporting frequency that are common among private-market participants. More specifically, while there is general agreement that a quarterly reporting cadence is usually appropriate, how private equity fund managers corroborate their internal assessments of fair value and the frequency at which they provide independent third-party validations can differ considerably across the GP universe.
As long as fair value remains something of a subjective measure, however, the prevailing question for GPs will revolve around the amount of rigor that goes into third-party validations and when, exactly, these independent assessments should accompany portfolio-company reporting. The easy answer—that it depends on the strategy and structure of the specific fund—is typically less than satisfying.
Read more
This article represents the author's views only and doesn't necessarily represent the views of PitchBook.
- Share:
-
-
-
-
Join the more than 1.5 million industry professionals who get our daily newsletter!